Royal Philips Electronics introduces InnerCool RTx Endovascular System

Royal Philips Electronics ( PHG, AEX: PHI) announced today its launch of the Philips InnerCool RTx Endovascular System for cooling and warming, which provides advanced whole body temperature modulation therapy in a closed-loop system from the inside out. The InnerCool RTx is a high-performance system that can rapidly raise and lower the body temperature of certain non-paralyzed, awake patients of all sizes in the intensive care setting.

The RTx cools and warms patients with a unique integrated temperature sensor catheter, which is placed below the heart via the femoral vein. Once in place, the closed-loop system modulates whole body temperature without fluid introduction or exchange by circulating cool or warm saline. This allows for precise temperature control while offering the fastest cooling and warming rates of any temperature management system currently on the market. This approach to therapeutic hypothermia rapidly achieves maximum cooling. It also allows for cooling of awake patients, which helps to avoid the risks inherent with paralytic agents such as masking seizures or inadequate levels of sedation. In addition to the new InnerCool RTx Endovascular System, Philips also offers the InnerCool STx Surface Pad System for cooling and warming, which provides a cost-effective and easy-to-use solution with an advanced design for non-invasive temperature modulation therapy.

Philips is leading the way in advanced temperature modulation therapy with comprehensive, science-driven solutions. Clinical research and technological developments are expanding the potential applications in which this innovative approach can help improve outcomes. As the only company to offer both endovascular and surface cooling and warming systems, Philips InnerCool family of products addresses the specific needs of patients, hospitals and clinical practices.

"The Philips InnerCool RTx Endovascular System brings significant advancements in temperature modulation therapy and makes this technology even easier to use," said Mike Miller, senior vice president and general manager, Cardiac Care, Philips Healthcare. "Because the InnerCool RTx has the fastest cooling and warming rates in the industry, it will be able to provide high performance in multiple clinical applications and settings."

The InnerCool RTx includes a programmable console with an intuitive touch screen interface.  It can be used with both a standard catheter and the Accutrol™ Catheter – the only temperature modulation catheter with an integrated temperature sensor. The average cooling rates for the RTx are 4-5 C/hr and the average warming rates are 2-3 C/hr.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Philips Healthcare. (2019, June 24). Royal Philips Electronics introduces InnerCool RTx Endovascular System. News-Medical. Retrieved on December 11, 2024 from https://www.news-medical.net/news/20100330/Royal-Philips-Electronics-introduces-InnerCool-RTx-Endovascular-System.aspx.

  • MLA

    Philips Healthcare. "Royal Philips Electronics introduces InnerCool RTx Endovascular System". News-Medical. 11 December 2024. <https://www.news-medical.net/news/20100330/Royal-Philips-Electronics-introduces-InnerCool-RTx-Endovascular-System.aspx>.

  • Chicago

    Philips Healthcare. "Royal Philips Electronics introduces InnerCool RTx Endovascular System". News-Medical. https://www.news-medical.net/news/20100330/Royal-Philips-Electronics-introduces-InnerCool-RTx-Endovascular-System.aspx. (accessed December 11, 2024).

  • Harvard

    Philips Healthcare. 2019. Royal Philips Electronics introduces InnerCool RTx Endovascular System. News-Medical, viewed 11 December 2024, https://www.news-medical.net/news/20100330/Royal-Philips-Electronics-introduces-InnerCool-RTx-Endovascular-System.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Philips introduces new web-based informatics platform to hasten drug research and biomarker discovery